These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18408737)

  • 1. ABT-737, proving to be a great tool even before it is proven in the clinic.
    Vaux DL
    Cell Death Differ; 2008 May; 15(5):807-8. PubMed ID: 18408737
    [No Abstract]   [Full Text] [Related]  

  • 2. ABT-737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug-resistance mechanisms.
    Kuroda J; Kimura S; Andreeff M; Ashihara E; Kamitsuji Y; Yokota A; Kawata E; Takeuchi M; Tanaka R; Murotani Y; Matsumoto Y; Tanaka H; Strasser A; Taniwaki M; Maekawa T
    Br J Haematol; 2008 Jan; 140(2):181-90. PubMed ID: 18028486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitors are unable to synergize with ABT-737 in killing primary chronic lymphocytic leukaemia cells in vitro.
    Ralli R; Banks KM; Wiegmans AP; Carney D; Seymour JF; Johnstone RW; Alsop AE
    Leukemia; 2012 Jun; 26(6):1433-5. PubMed ID: 22289920
    [No Abstract]   [Full Text] [Related]  

  • 4. Decreased sensitivity of 17p-deleted chronic lymphocytic leukemia cells to a small molecule BCL-2 antagonist ABT-737.
    Kojima K; Duvvuri S; Ruvolo V; Samaniego F; Younes A; Andreeff M
    Cancer; 2012 Feb; 118(4):1023-31. PubMed ID: 21761401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Bcl-2 family proteins in adult T-cell leukemia/lymphoma: in vitro and in vivo effects of the novel Bcl-2 family inhibitor ABT-737.
    Ishitsuka K; Kunami N; Katsuya H; Nogami R; Ishikawa C; Yotsumoto F; Tanji H; Mori N; Takeshita M; Miyamoto S; Tamura K
    Cancer Lett; 2012 Apr; 317(2):218-25. PubMed ID: 22138435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting multiple arms of the apoptotic regulatory machinery.
    Dai Y; Grant S
    Cancer Res; 2007 Apr; 67(7):2908-11. PubMed ID: 17409392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins.
    Tagscherer KE; Fassl A; Campos B; Farhadi M; Kraemer A; Böck BC; Macher-Goeppinger S; Radlwimmer B; Wiestler OD; Herold-Mende C; Roth W
    Oncogene; 2008 Nov; 27(52):6646-56. PubMed ID: 18663354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-(4-hydroxyphenyl)retinamide promotes apoptosis of resting and proliferating B-cell chronic lymphocytic leukemia cells and potentiates fludarabine and ABT-737 cytotoxicity.
    Bruno S; Ghiotto F; Tenca C; Mazzarello AN; Bono M; Luzzi P; Casciaro S; Recchia A; Decensi A; Morabito F; Fais F
    Leukemia; 2012 Oct; 26(10):2260-8. PubMed ID: 22475870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia.
    Mason KD; Khaw SL; Rayeroux KC; Chew E; Lee EF; Fairlie WD; Grigg AP; Seymour JF; Szer J; Huang DC; Roberts AW
    Leukemia; 2009 Nov; 23(11):2034-41. PubMed ID: 19641525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoring cancer's death sentence.
    Letai A
    Cancer Cell; 2006 Nov; 10(5):343-5. PubMed ID: 17097553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gossypol overcomes stroma-mediated resistance to the BCL2 inhibitor ABT-737 in chronic lymphocytic leukemia cells ex vivo.
    Soderquist R; Bates DJ; Danilov AV; Eastman A
    Leukemia; 2013 Nov; 27(11):2262-4. PubMed ID: 23640104
    [No Abstract]   [Full Text] [Related]  

  • 12. Concurrent up-regulation of BCL-XL and BCL2A1 induces approximately 1000-fold resistance to ABT-737 in chronic lymphocytic leukemia.
    Vogler M; Butterworth M; Majid A; Walewska RJ; Sun XM; Dyer MJ; Cohen GM
    Blood; 2009 Apr; 113(18):4403-13. PubMed ID: 19008458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycolysis inhibition targets Mcl-1 to restore sensitivity of lymphoma cells to ABT-737-induced apoptosis.
    Meynet O; Bénéteau M; Jacquin MA; Pradelli LA; Cornille A; Carles M; Ricci JE
    Leukemia; 2012 May; 26(5):1145-7. PubMed ID: 22076465
    [No Abstract]   [Full Text] [Related]  

  • 14. ABT-737, a BH3 mimetic, induces glutathione depletion and oxidative stress.
    Howard AN; Bridges KA; Meyn RE; Chandra J
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):41-54. PubMed ID: 19404643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABT-737 overcomes Bcl-2 mediated resistance to doxorubicin-DNA adducts.
    Ugarenko M; Nudelman A; Rephaeli A; Kimura K; Phillips DR; Cutts SM
    Biochem Pharmacol; 2010 Feb; 79(3):339-49. PubMed ID: 19737541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of apoptosis in pediatric acute lymphoblastic leukemia (ALL) cells by the therapeutic opioid methadone and effective synergy with Bcl-2 inhibition.
    Singh A; Jayanthan A; Farran A; Elwi AN; Kim SW; Farran P; Narendran A
    Leuk Res; 2011 Dec; 35(12):1649-57. PubMed ID: 21798596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting mitochondria emerges as therapeutic strategy.
    Garber K
    J Natl Cancer Inst; 2005 Dec; 97(24):1800-1. PubMed ID: 16368937
    [No Abstract]   [Full Text] [Related]  

  • 18. Bcl-2 inhibitors reduce steroid-insensitive airway inflammation.
    Tian BP; Xia LX; Bao ZQ; Zhang H; Xu ZW; Mao YY; Cao C; Che LQ; Liu JK; Li W; Chen ZH; Ying S; Shen HH
    J Allergy Clin Immunol; 2017 Aug; 140(2):418-430. PubMed ID: 28043871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The BH3-mimetic ABT-737 inhibits allogeneic immune responses.
    Cippà PE; Kraus AK; Edenhofer I; Segerer S; Chen J; Hausmann M; Liu Y; Guimezanes A; Bardwell PD; Wüthrich RP; Fehr T
    Transpl Int; 2011 Jul; 24(7):722-32. PubMed ID: 21615547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Progress in small-molecule inhibitors of Bcl-2 family proteins].
    Tang Y; Zhang DY; Wu XM
    Yao Xue Xue Bao; 2008 Jul; 43(7):669-77. PubMed ID: 18819468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.